Transcription factor 4 and Fuchs’ endothelial corneal dystrophy (FECD) association: Perspectives for novel targeted therapeutics Angeliki MargoniKostas A. PapavassiliouAthanasios G. Papavassiliou in Eye Article 02 November 2025
On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical models Filippo BirocchiAntonio J. AlmazanMarcela V. Maus in Nature Communications Article Open access 01 November 2025
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies Elizabeth J. CarstensKazuki TakahashiEric L. Smith in Nature Communications Article Open access 01 November 2025
Mecasermin for the treatment of Rett Syndrome: a systematic review Fernanda Cristina Poscai RibeiroMaria Luiza AlvesKleber Fernando Pereira in Neurogenetics Article 01 November 2025
Galangin 3-methyl ether alleviates mouse hypertrophic cardiomyopathy via targeting HDAC2 and subsequently inactivating the PI3K-AKT signaling pathway Ke ZhangTao XuChao Ye in Acta Pharmacologica Sinica Article Open access 01 November 2025
Computational identification of cross-reactive TCR epitopes with ARDitox Victor Murcia PienkowskiTamara BoschertAgnieszka Blum in Journal of Cancer Research and Clinical Oncology Article Open access 01 November 2025
Antiviral candidates for enterovirus 71: targeting viral proteome and stage-specific lifecycle interventions Jiayi ChenTianqi ZhaoBinghui Xia in Virology Journal Article Open access 31 October 2025
MicroRNA expression in peripheral blood of children with asthma and the role of miR-31-5p in childhood asthma progression Wenwei LuoGang LiZhengrong Chen in Scientific Reports Article Open access 31 October 2025
Inhibition of miR-4284 could reduce apoptosis and neuroinflammation by targeting APBA1/JAK1/STAT3 signaling in Alzheimer’s disease Jiyun ChoiJinsu HwangSujeong Jang in Cell & Bioscience Article Open access 31 October 2025
Upregulation of CCK3R leading to the suppression of chronic seizures Ling HeLiyang ZhangJufang He in Translational Psychiatry Article Open access 31 October 2025
Development of antibody drug conjugates targeting epithelial membrane protein 2-highly expressed lung cancer Mengge ZhengSu HangHaipeng Liu in Cell Death & Disease Article Open access 31 October 2025
Targeting SET to counteract Lyn activation demonstrates anti-cancer potential in diffuse large B-cell lymphoma Ji-Lin ChenPei-Yi ChuChun-Yu Liu in Clinical and Experimental Medicine Article Open access 31 October 2025
WT1 gene: a potential therapeutic target for multiple cancer treatment strategies Tetsuyuki HirahataReeshan Ul QuraishReezan Ul Quraish in Clinical and Experimental Medicine Article Open access 31 October 2025
Immunomodulation of behavior impairment via spleen-specific targeting lipid nanoparticles in a MeCP2 transgenic mouse model Shu ZhangYaxi LiTianfu Wu in Scientific Reports Article Open access 31 October 2025
Personalized gene editing helped one baby: can it be rolled out widely? in Nature Article 31 October 2025
The role of TEAD4 gene in the Hippo signaling pathway in triple-negative breast cancer and targeted therapy strategies Xueliang ZhangTao WangYan Liang in BMC Medical Genomics Article Open access 30 October 2025
Dealmakers seek to expand the druggable proteome Peter Kirkpatrick in Biopharma Dealmakers Article 30 October 2025
Genome-wide association, single-cell, and spatial transcriptomics analyses reveal the role of the STK24-expressing positive cells in LUAD progression and the tumor microenvironment, identifying STK24 as a potential therapeutic target Junzhi LiuHuimin LiMeng Hou in Journal of Translational Medicine Article Open access 30 October 2025
Targeting ESM-1 inhibits spinal metastasis by disrupting tumor-endothelial adhesion Seong Jun KimWan-Kyu KoSeil Sohn in Molecular Biomedicine Article Open access 30 October 2025
RECQL1 as a potential therapeutic target for PARP inhibitor-resistant ovarian cancer Hiroyuki YoshidaJiarui LiKeiichi Fujiwara in Scientific Reports Article Open access 30 October 2025
